Durvalumab Shows Activity in Patients who Progressed on Platinum-Based Chemo February 28, 2017Vol.40 No.02
Drugs & Targets FDA Approves Opdivo for Urothelial Carcinoma Indication February 28, 2017Vol.40 No.02
Opdivo Demonstrated Improved Survival in Advanced Gastric Cancer in Phase III Study February 28, 2017Vol.40 No.02
Study Shows Only Nuclear-Localized AR-V7 Predictive of Benefit for Patients with Metastatic Disease January 25, 2017Vol.40 No.01
Study Finds Biological Explanation for Racial Disparities in Survival for Certain Cancers January 25, 2017Vol.40 No.01
Drugs & Targets Tecentriq receives priority review for treatment of urothelial carcinoma January 25, 2017Vol.40 No.01
